aod9604 peptide weight loss AOD 9604: The Management - Vida Wellness aod9604 weight loss evidence clinical
Description
The 100mg cohort showed statistically significant reductions in visceral adipose tissue (8.3% vs baseline) and improvements in insulin sensitivity (HOMA-IR reduction of 18.7%), but no hepatotoxicity signals emerged across any dose tier
Smaller volumes mean less discomfort, less chance of medication leaking from the injection site, and more doses per vial
This study investigated how quickly AOD9604 breaks down in blood and what products it forms when it does
Liang, Y., et al
